Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
{arrow_up} Back to top

Lenalidomide 20 mg capsules

Discontinued
Active Ingredient:
lenalidomide
Company:  
ADVANZ Pharma See contact details
ATC code: 
L04AX04
{info_black}
About Medicine
{medical_services}
Prescription only medicine
Healthcare Professionals (SmPC) Patient Leaflet (PIL) Risk Materials
{arrow_left}
{arrow_right}

Educational Risk Minimisation Materials to help reduce the risk associated with using this medicine.

{pdf_link}

Healthcare Professional (HCP) Guide

{healthcare_pro_orange} For Healthcare Professionals

Lenalidomide Pregnancy Prevention Programme

Information for Healthcare Professionals Prescribing or Dispensing Lenalidomide

This brochure contains the information needed for the prescribing and dispensing of Lenalidomide, including information about the Pregnancy Prevention Programme (PPP).

{pdf_link}

Lenalidomide Adverse Event Form

Lenalidomide Adverse Event Form

{pdf_link}

Lenalidomide Pregnancy Outcome Form

Lenalidomide Pregnancy Outcome Form

{pdf_link}

Lenalidomide Pregnancy Report Form

Lenalidomide Pregnancy Report Form

{pdf_link}

Lenalidomide RAF for Males

Lenalidomide Pregnancy Prevention Programme Male Risk Awareness Form

Risk Awareness Form for counselling the patient to ensure the patient is fully informed about the safe use of lenalidomide

{pdf_link}

Lenalidomide RAF for WCBP

Lenalidomide Pregnancy Prevention Programme Woman of Childbearing Potential Risk Awareness Form

Risk Awareness Form for counselling the patient to ensure the patient is fully informed about the safe use of lenalidomide

{pdf_link}

Lenalidomide RAF for WNCBP

Lenalidomide Pregnancy Prevention Programme Women of Non-Childbearing Potential

Risk Awareness Form for counselling the patient to ensure the patient is fully informed about the safe use of lenalidomide

{pdf_link}

Patient Information Card

Information for Patients and Healthcare Professionals:

Lenalidomide is structurally related to thalidomide and is expected to cause severe birth defects or death to an unborn baby

{pdf_link}

Patient Information Guide

Lenalidomide Pregnancy Prevention Programme

Information for Patients taking Lenalidomide

You are trying to reach document intended for healthcare professionals only.

Are you a healthcare professional?

Log in or sign up to avoid further verifications.

ADVANZ Pharma
Company image
Address
Dashwood House, 69 Old Broad Street, London, EC2M 1QS, UK
Telephone
+44 (0)208 588 9131
Medical Information Direct Line
+44 (0)208 588 9131
Medical Information e-mail
[email protected]
WWW
www.advanzpharma.com
Customer Care direct line
+44 (0)208 588 9273